DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

Monday, 19 October 2015

BENITA SAKLANI MAINDOLA

BENITA SAKLANI MAINDOLA

BENITA SAKLANI MAINDOLA

binnisaklani777@gmail.com
binnisaklani@yahoo.com
http://www.slideshare.net/BENITASAKLANIMAINDOL
https://in.linkedin.com/pub/benita-saklani-maindola/20/6a0/9b8


Summary

• Working in GLP environment while ensuring adherence to compliance
• Writing more than 250 toxicology study reports
• Developing analytical method for researches while ensuring stringent adherence to quality standards, norms & practices, identifying gaps and taking corrective action
• Developing SOP’s, study plan, schedule & reports in accordance with GLP (Good Laboratory Practices)
• Sound knowledge of OECD, ISO, USP, ICH, CIB-RC, DRUG AND COSMETIC ACT, DBT, Schedule Y and ISO guidelines for pre-clinical testing
• Laboratory animal management & experimental techniques in safety assessment studies in a GLP accredited state of art facility
• Conducting preclinical & clinical studies in compliance with Good Laboratory Practices
• Managing the spectrum of laboratory operations including spanning testing, method development and coordination with cross-functional departments
• Enterprising leader with excellent planning, problem solving, interpersonal and analytical skills.
Writing more than 250 toxicology study reports
• Developing analytical method for researches while ensuring stringent adherence to quality standards, norms & practices, identifying gaps and taking corrective action
• Developing SOP’s, study plan, schedule & reports in accordance with GLP (Good Laboratory Practices) • Sound knowledge of OECD, ISO, USP, ICH, CIB-RC, DRUG AND COSMETIC ACT, DBT, Schedule Y and ISO guidelines for pre-clinical testing
• Laboratory animal management & experimental techniques in safety assessment studies in a GLP accredited state of art facility
• Conducting preclinical & clinical

Experience

STUDY DIRECTOR

TOXICOLOGY DEPARTMENT- KRISH BIOTECH RESEARCH PVT. LTD., OECD GLP CERTIFIED FACILITY
September 2014 – Present (1 year 2 months)KRISH BIOTECH RESEARCH PVT. LTD, WESTBENGAL
STUDY DIRECTOR FOR TOXICOLOGICAL STUDIES

SCIENTIST

shri ram institute for industrial research
November 2007 – August 2014 (6 years 10 months)
CONDUCTION OF TOXICOLOGICAL STUDES(SHORT TERM AND LONG TERM) FOR AGROCHEMICALS, MEDICAL DEVICES, COSMETICS, FOOD ADDITIVES, BIOLOGIC MATERIALS ETC AS STUDY DIRECTOR FOR GLP STUDIES

QUALITY CONTROL

haridwar
March 2007 – October 2007 (8 months)MPIL, HARIDWAR
QUALITY CONTROL OF IN-PROCESS.

Education

TOXICOLOGY DEPARTMENT- KRISH BIOTECH RESEARCH PVT. LTD., OECD GLP CERTIFIED FACILITY
http://www.krishbiotech.com/

Krish Biotech Research Pvt. Ltd - Facebook

https://www.facebook.com/.../Krish-Biotech-Research-Pvt-Ltd/17605363...
 

krishbiotech
krishbiotech
krishbiotech
krishbiotech

Krish Biotech

Raghib Husain

Dr. Raghib Husain, Sr. Vice President, Head of R&D
Raghib Husain is an accomplished toxicologist with about 25 years of extensive experience in preclinical research. Prior to joining KBRPL, he has worked in major Indian pharmaceutical companied like Wockhardt, ZydusCadila, Glenmark, Jubilant Biosys and PiramalLifesciences. He has handled multiple programs in cancer, metabolic disorder, pain and inflammation and made significant contribution in several discovery and development projects. Raghib has created safety profile of molecules (small & large) for regulatory submissions/presentations to national and international regulatory agencies for approval at different stages of clinical development.
Raghib has designed & established the Animal Facilities, DMPK, GLP Toxicology, Pharmacology & Radioactive labs in the research centres at Piramal, Jubilant Biosys, Glenmark, Zydus-Cadila and Wockhardt. He established the GLP facility at the NCE research unit of Piramal Enterprises and was also instrumental in setting up GLP system at KBRPL which is now certified for OECD-GLP compliance by National GLP Compliance and Monitoring Authority of India. Raghib received his Ph.D. degree from Indian Institute of Toxicology Research, Lucknow. He has also undergone post-doctoral research training at Turku University, Turku, Finland and Imperial College, London. He has published 20 articles in the journals of international repute and also member of Society of Toxicology, US and British Association of Research Quality Assurance, UK.

 

Krish Biotech Research Private Limited (KBRPL) is an independent research based company promoted by the KrishiRasayan group (a five decade old Kolkata based Chemicals Company). Krish Biotech is a contact researchorganization providing integrated discovery, development and regulatory services.
Our R&D facility is located in Kalyani, a progressive, well planned and dynamic town about 50 KMs north of Kolkata in the Nadia district of West Bengal.Kalyaniis famous for its centers of higher education including the University of Kalyani, Bidhan Chandra KrishiViswavidyalaya (Agricultural University), the West Bengal University of Technology, NetajiSubhas Open University and numerous other centres of general, special and technical education.
KBRPL’s state of the art laboratory is well designed and developed based on the requirement of Organization for Economic Co-operation and Development (OECD), Principles of Good Laboratory Practice (GLP).
KBRPL is one of its kinds in the Eastern part of India which can provide integrated discovery, development and regulatory services, across the agrochemical, chemical, pharmaceutical and medical device industries. The futuristic and leadership approach and thinking of KBRPL is evident from the fact that it is the first and only GLP Compliant lab in the whole of eastern and north eastern India.
KBRPL follows high standard of national and international safety procedures and provide safe working environment to all employees.
A qualified team of scientists and excellent management with defined work ethics provide quality and efficient services.
Head Office
29, Lala Lajpat Rai Sarani (Elgin Road),
Kolkata – 700020 , India.
Phone: (033) 71081010
Email: ho@krishbiotech.com
Our Location
 
R & D Facility
T-1, QK-17 (Part) WBIDC
Kalyani, Phase III, Nadia
West Bengal 741 235 ,INDIA
Phone: (033) 2582-8850
Email: bd@krishbiotech.com
Vinod.r@
Kalyani, West Bengal, INDIA








//////////Kalyani, BENITA SAKLANI MAINDOLA, West Bengal, INDIA,

No comments:

Post a Comment